PAGP
Q4 2026 EPS Estimate
$0.43
Nov 4, 2026 · Reports before open
Revenue Estimate
$13.27B
FY2026E EPS$1.51
FY2027E EPS$2.01

Analyst Sentiment

Wall St. Consensus
Buy
26 analysts·High coverage
66
Score
17 Buy (65%)8 Hold (31%)1 Sell (4%)
Rating Breakdown
Strong Buy
14%
Buy
1662%
Hold
831%
Sell
14%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$23.00
-12.5%
Consensus
$25.00
-4.9%
Bull
$28.00
+6.5%
12-Month Target Range26 analysts
$23.00$25.00$28.00
Current $26.28Consensus
Current Price
$26.28
Above Consensus
$1.28

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+3.22%
EPS+33.31%
FY2028
Rev+3.31%
EPS+3.92%
FY2029
Rev-35.24%
EPS+9.02%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$54.03B$55.77B$57.61B$37.31B$35.75B
Low$50.92B$54.25B$51.87B$35.16B$33.69B
High$56.92B$57.29B$61.46B$39.31B$37.66B
EBITDA Avg$2.96B$3.05B$3.15B$2.04B$1.96B
Low$2.79B$2.97B$2.84B$1.93B$1.84B
High$3.12B$3.14B$3.37B$2.15B$2.06B
EBIT Avg$1.89B$1.95B$2.01B$1.30B$1.25B
Low$1.78B$1.90B$1.81B$1.23B$1.18B
High$1.99B$2.00B$2.15B$1.37B$1.32B
Net Income Avg$298M$394M$403M$451M$469M
Low$267M$321M$330M$418M$434M
High$328M$467M$475M$483M$502M
EPS Avg$1.51$2.01$2.09$2.28$2.37
Low$1.35$1.62$1.67$2.11$2.19
High$1.66$2.36$2.40$2.44$2.54
Analysts (Rev / EPS)3 / 34 / 35 / 52 / 12 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$13.16B$13.24B$13.16B$13.59B$13.88B$14.09B$13.92B$14.21B
Low$12.85B$11.57B$12.26B$12.66B$12.94B$13.13B$12.97B$13.24B
High$13.47B$14.89B$14.16B$14.62B$14.94B$15.16B$14.97B$15.29B
EBITDA Avg$721M$725M$721M$744M$760M$771M$762M$778M
Low$704M$634M$672M$693M$708M$719M$710M$725M
High$738M$815M$775M$801M$818M$830M$820M$837M
EBIT Avg$460M$463M$460M$475M$485M$493M$487M$497M
Low$449M$405M$429M$443M$452M$459M$454M$463M
High$471M$521M$495M$511M$522M$530M$524M$535M
Net Income Avg$102M$95M$91M$99M$101M$94M$90M$92M
Low$80M$86M$83M$90M$92M$86M$82M$84M
High$122M$104M$100M$109M$111M$104M$99M$101M
EPS Avg$0.52$0.48$0.46$0.50$0.51$0.48$0.46$0.47
Low$0.41$0.44$0.42$0.46$0.47$0.43$0.42$0.42
High$0.62$0.53$0.50$0.55$0.56$0.52$0.50$0.51
Analysts (Rev / EPS)3 / 15 / 14 / 14 / 14 / 14 / 13 / 13 / 1

Earnings Surprises

Recent Analyst Actions

Aug 18, 2026Morgan Stanley
Plains GP Holdings price target raised to $28 from $26 at Morgan Stanley
Target:$28.00
+6.7%from $26.25
Jul 16, 2026Barclays
Plains GP Holdings price target raised to $23 from $21 at Barclays
Target:$23.00
-8.4%from $25.10
Jun 8, 2026Mizuho Securities
Plains GP Holdings price target raised to $27 from $25 at Mizuho
Target:$27.00
+10.4%from $24.46
Jun 3, 2026Goldman Sachs
Plains GP Holdings upgraded to Neutral from Sell at Goldman Sachs
Target:$24.00
-3.3%from $24.83
May 20, 2026Morgan Stanley
Plains GP Holdings price target raised to $26 from $24 at Morgan Stanley
Target:$26.00
+1.3%from $25.68
Apr 10, 2026Barclays
Plains GP Holdings price target raised to $21 from $18 at Barclays
Target:$21.00
-11.2%from $23.64
Mar 6, 2026Stifel Nicolaus
Plains GP Holdings, L.P (PAGP) PT Raised to $25 at Stifel Amid Volatility, Higher Oil Prices
Target:$25.00
+5.4%from $23.71
Jan 23, 2026Mizuho Securities
Plains GP Holdings price target raised to $23 from $22 at Mizuho
Target:$23.00
+13.2%from $20.32
Nov 25, 2025Morgan Stanley
Plains GP Holdings price target raised to $22 from $20 at Morgan Stanley
Target:$22.00
+19.9%from $18.34
Oct 24, 2025Raymond James
Plains GP Holdings price target lowered to $22 from $24 at Raymond James
Target:$22.00
+23.5%from $17.81
Oct 7, 2025Barclays
Plains GP Holdings price target lowered to $17 from $18 at Barclays
Target:$17.00
-5.2%from $17.93
Aug 26, 2025Morgan Stanley
Plains GP Holdings price target lowered to $20 from $22 at Morgan Stanley
Target:$20.00
+6.7%from $18.75
Mar 25, 2025Morgan Stanley
Plains GP Holdings price target raised to $23 from $19 at Morgan Stanley
Target:$23.00
+6.9%from $21.52
Dec 18, 2024Wells Fargo
Plains GP Holdings downgraded to Equal Weight from Overweight at Wells Fargo
Target:$20.00
+10.2%from $18.15
Aug 5, 2024Stifel Nicolaus
Plains GP Holdings, L.P (PAGP) PT Raised to $23 at Stifel
Target:$23.00
+29.1%from $17.81
Apr 16, 2024Stifel Nicolaus
Plains GP Holdings price target raised to $22 from $18 at Stifel
Target:$22.00
+19.0%from $18.48
Apr 12, 2024Barclays
Plains GP Holdings price target raised to $18 from $16 at Barclays
Target:$18.00
-5.1%from $18.96
Apr 12, 2024Goldman Sachs
Plains GP Holdings, L.P (PAGP) PT Raised to $16 at Goldman Sachs
Target:$16.00
-15.6%from $18.96
Dec 9, 2022Citigroup
Citigroup Initiates Coverage On Plains GP Holdings with Buy Rating, Announces Price Target of $14
Target:$14.00
+14.2%from $12.26
Dec 2, 2022Truist Financial
Truist Securities Maintains Buy on Plains GP Holdings, Raises Price Target to $15
Target:$15.00
+16.3%from $12.90
Nov 21, 2022J.P. Morgan
JP Morgan Downgrades Plains GP Holdings to Neutral, Lowers Price Target to $14
Target:$14.00
+12.4%from $12.46
Aug 14, 2022Stifel Nicolaus
Plains GP Holdings upgraded to Buy from Hold at Stifel
Target:$16.00
+35.1%from $11.84
Aug 4, 2022UBS
UBS Maintains Buy on Plains GP Holdings, Raises Price Target to $18
Target:$18.00
+58.6%from $11.35
Jul 8, 2022UBS
UBS Maintains Buy on Plains GP Holdings, Raises Price Target to $17
Target:$17.00
+64.6%from $10.33
May 2, 2022Truist Financial
Truist Securities Assumes Plains GP Holdings at Buy, Announces Price Target of $13
Target:$13.00
+16.3%from $11.18
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.